News
The FDA rolls out its own AI to speed up clinical reviews and scientific evaluations
The FDA has launched the generative AI tool, Elsa, agency-wide to help its employees with everything from clinical reviews to investigations. Sure, we're living in a time of widespread disinformation and pushbacks against science, but why not rush things through with AI?
A new Food and Drug Administration AI tool that could speed up reviews and approvals of medical devices such as pacemakers ...
AI-driven Clairity Breast platform, now FDA-approved, predicts five-year breast cancer risk from mammograms, enhancing early ...
Following a successful pilot, the Food and Drug Administration unveiled its in-house large language model designed to help ...
The FDA may be facing a 4% cut to its overall budget courtesy of the Trump administration, but that hasn’t stopped the agency ...
The FDA launched Elsa, its first generative AI tool, to streamline reviews and modernize agency workflow across all centers.
The FDA rolled out a generative AI tool for speeding regulatory reviews, announcing its launch nearly a month ahead of a June ...
The FDA launched an artificial intelligence tool Monday dubbed Elsa, with Commissioner Marty Makary hyping the effort’s early ...
The FDA is moving at breakneck speed to roll out a generative artificial intelligence (AI) tool for speeding up regulatory ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback